These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 11283668)

  • 1. Vascular endothelial growth factor enhances atherosclerotic plaque progression.
    Celletti FL; Waugh JM; Amabile PG; Brendolan A; Hilfiker PR; Dake MD
    Nat Med; 2001 Apr; 7(4):425-9. PubMed ID: 11283668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque.
    Celletti FL; Hilfiker PR; Ghafouri P; Dake MD
    J Am Coll Cardiol; 2001 Jun; 37(8):2126-30. PubMed ID: 11419898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis.
    Moulton KS; Vakili K; Zurakowski D; Soliman M; Butterfield C; Sylvin E; Lo KM; Gillies S; Javaherian K; Folkman J
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4736-41. PubMed ID: 12682294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.
    Horowitz JR; Rivard A; van der Zee R; Hariawala M; Sheriff DD; Esakof DD; Chaudhry GM; Symes JF; Isner JM
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2793-800. PubMed ID: 9409257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis.
    Lemström KB; Krebs R; Nykänen AI; Tikkanen JM; Sihvola RK; Aaltola EM; Häyry PJ; Wood J; Alitalo K; Ylä-Herttuala S; Koskinen PK
    Circulation; 2002 May; 105(21):2524-30. PubMed ID: 12034660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.
    Shah PK; Yano J; Reyes O; Chyu KY; Kaul S; Bisgaier CL; Drake S; Cercek B
    Circulation; 2001 Jun; 103(25):3047-50. PubMed ID: 11425766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes.
    Pakala R; Watanabe T; Benedict CR
    Cardiovasc Radiat Med; 2002; 3(2):95-101. PubMed ID: 12699839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment.
    Lucerna M; Zernecke A; de Nooijer R; de Jager SC; Bot I; van der Lans C; Kholova I; Liehn EA; van Berkel TJ; Yla-Herttuala S; Weber C; Biessen EA
    Blood; 2007 Jan; 109(1):122-9. PubMed ID: 16990600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
    Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
    Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.
    Moore MA; Hattori K; Heissig B; Shieh JH; Dias S; Crystal RG; Rafii S
    Ann N Y Acad Sci; 2001 Jun; 938():36-45; discussion 45-7. PubMed ID: 11458524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis.
    Zhao Q; Egashira K; Inoue S; Usui M; Kitamoto S; Ni W; Ishibashi M; Hiasa Ki K; Ichiki T; Shibuya M; Takeshita A
    Circulation; 2002 Mar; 105(9):1110-5. PubMed ID: 11877364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma.
    Inoue M; Itoh H; Tanaka T; Chun TH; Doi K; Fukunaga Y; Sawada N; Yamshita J; Masatsugu K; Saito T; Sakaguchi S; Sone M; Yamahara Ki ; Yurugi T; Nakao K
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):560-6. PubMed ID: 11304473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.
    Couffinhal T; Kearney M; Witzenbichler B; Chen D; Murohara T; Losordo DW; Symes J; Isner JM
    Am J Pathol; 1997 May; 150(5):1673-85. PubMed ID: 9137092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit.
    Wong CG; Rich KA; Liaw LH; Hsu HT; Berns MW
    Curr Eye Res; 2001 Feb; 22(2):140-7. PubMed ID: 11402391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.
    Lu Y; Zhang M; Zhao P; Jia M; Liu B; Jia Q; Guo J; Dou L; Li J
    Mol Med Rep; 2017 Jul; 16(1):647-653. PubMed ID: 28560429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo.
    Melter M; Reinders ME; Sho M; Pal S; Geehan C; Denton MD; Mukhopadhyay D; Briscoe DM
    Blood; 2000 Dec; 96(12):3801-8. PubMed ID: 11090063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
    Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells.
    Wild R; Dhanabal M; Olson TA; Ramakrishnan S
    Br J Cancer; 2000 Oct; 83(8):1077-83. PubMed ID: 10993657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.